News Archives - NetworkNewsWire

TuesdayNov 24, 2020 7:45 am

NetworkNewsAudio – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces FDA Filing of IND for its Brain Cancer Drug Berubicin

Related Press Release CNS Pharmaceuticals (NASDAQ: CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, today announced that it has submitted an Investigational New Drug ("IND") application, which has been accepted for review, to the U.S. Food and Drug Administration ("FDA") for Berubicin in the treatment of Glioblastoma Multiforme ("GBM"). The Company plans to evaluate the efficacy of Berubicin in a Phase 2 Trial for adults with GBM who have failed first-line therapy and commence the trial within the first quarter of…

FridayNov 20, 2020 8:30 am

NetworkNewsAudio – GoldHaven Resources Corp. (CSE: GOH) (OTCQB: ATUMF) Ideally Positioned as Precious Metal Investment Demand Rises

Related Editorial Investors are flocking to gold, silver and other precious metals in record numbers. One firm, BullionVault, reports that in the past six months demand to invest in gold, silver and platinum has reached almost half a billion dollars. “Net of client selling, investing in physical bullion on our peer-to-peer platform — first opened in 2005 — has now topped $442 million since the pandemic reached Europe and North America in March,” the company said. Mining companies around the world are benefitting from this rising investment tide, as they work to strengthen their positions, increase their holdings and ultimately…

FridayNov 20, 2020 8:30 am

NetworkNewsAudio – Josemaria Resources Inc. (TSX: JOSE) (OTCQB: JOSMF) Sits Pretty as Gold, Copper Prices Reach Record Highs

Related Editorial The surge in the price of gold has been well documented this year. The precious metal closed above $2,000 an ounce earlier this year, leading experts to forecast future prices from $2,300 (Goldman Sachs) to as high as $3,000 (Bank of America) in the coming months. In addition, copper prices have also risen to their highest levels in more than two years, climbing to more than $6,800 a ton. These numbers bode well for companies in the precious metals space, especially companies such as Josemaria Resources Inc. (TSX: JOSE) (OTCQB: JOSMF) (JOSE Profile), which has interests in both…

FridayNov 13, 2020 8:30 am

NetworkNewsAudio – Cybin Inc. (NEO: CYBN) At the Forefront of Psychedelic Therapeutic Protocols, Development

Related Editorial Big pharma and life science companies are making big news these days. The drug-development space is seeing strong investor interest as these companies make breakthrough advancements that address vast unmet medical needs. Strategic M&A moves are adding spice to the gumbo for investors as pioneering research remains focused on providing life-changing treatments for those suffering from a myriad of disorders. One of the largest and trickiest medical disorders of mankind may be on the cusp of more effective treatment. Depression is often kept in the dark and not talked about, but it is estimated that more than 17…

FridayOct 23, 2020 8:30 am

NetworkNewsAudio – 180 Life Sciences Corp. Founders Leverage History of Success Developing, Selling New Drugs to Big Pharma

Related Editorial Pharmaceutical companies invest enormous amounts of time and money on the research and development of new drugs, typically years in the making and costing millions of dollars. Only occasionally is a new drug developed that’s approved and generates more than $1 billion per year in sales, a benchmark in the industry commonly called a “blockbuster.” Blockbusters are scarce, but the proverbial quest for blockbuster drugs continues unabated because of vast unmet medical needs and because blockbuster therapeutics can be worth tens of billions of dollars during their patent-protected lives. Little wonder that pharmaceutical giants often buy up promising…

FridayOct 16, 2020 8:30 am

NetworkNewsAudio – KBL Merger Corp. IV (NASDAQ: KBLM) Identifies 180 Life Sciences Corp. as Perfect Target; Companies Set to Merge

Related Editorial The year 2020 has already seen 127 SPAC IPOs, which have collectively raised over $48.5 billion in proceeds — more than the past ten years combined. A special purpose acquisition company (SPAC) is essentially a blank-check company formed to raise capital through an IPO with the sole intent of buying or merging with another operating company. SPACs have evolved to become an expedited and cost-effective way of doing an M&A deal and have been utilized by multiple Wall Street heavyweights. Going public via a SPAC enables a company to get a deal done in weeks instead of months,…

FridayOct 16, 2020 8:30 am

NetworkNewsAudio – Cybin Corp. Targeting Underserved Mental Illnesses with Drugs Derived from Psychedelics

Related Editorial Compelling evidence of the therapeutic benefits of psychedelic drugs appears in multiple scientific studies. Several clinical trials are underway in the United States and worldwide to investigate the therapeutic effects of psilocybin, the active component in the fungi known colloquially as "magic mushrooms." There is new hope for treating such debilitating disorders as depression, anxiety, post-traumatic stress disorder, anorexia, obsessive-compulsive disorder, and addiction. With more than $6.8 billion on the line by 2027, companies at the vanguard of the psychedelic therapeutic drug market could reap enormous benefits in the coming years. Some of these companies, such as Cybin…

MondayOct 05, 2020 8:30 am

NetworkNewsAudio – 180 Life Sciences Corp. Dedicated to Developing Groundbreaking Anti-Inflammatory Drugs

Related Editorial Inflammation typically occurs in the body as a natural response to threats such as infection or injury, but chronic inflammation can cause severe damage and even death. Inflammation is a well-known symptom of multiple infectious diseases. However, multidiscipline research strongly suggests that inflammation is also closely linked with a broad range of noninfectious diseases. The critical aspects of the interplay between inflammation and disease may well be the key to development of a new generation of drugs to treat previously untreatable diseases, sparking a flurry of biotech research and development in the field. At the vanguard of this…

FridayOct 02, 2020 8:30 am

NetworkNewsAudio – Kaival Brands Innovations Group Inc. (KAVL) to Develop Smoking Cessation Products Using Purified, Synthetic Nicotine

Related Editorial Approximately 1,300 people die every day as a result of smoking, and more than 16 million Americans are living with a disease caused by smoking. These alarming numbers aren’t going unnoticed, and companies with expertise in the space are seizing the opportunity to provide solutions designed to help smokers kick the habit. One of those companies, Kaival Brands Innovations Group Inc. (OTCQB: KAVL) (KAVL Profile), has just acquired a patent covering the creation of all synthetic nicotine smoking cessation and synthetic nicotine addiction therapy products; the company is also creating a subsidiary that will own the patent and…

MondaySep 28, 2020 8:30 am

NetworkNewsAudio – The Alkaline Water Company Inc. (CSE: WTER) (NASDAQ: WTER) Sees Record Growth as Consumers Crave Healthier Beverage Options

Related Editorial Soda sales over the past 15 years have fallen significantly, leaving major beverage brands looking for alternative ways to expand their portfolios to capture a portion of the various new craft beverages that consumers drink each day. Many of these large companies are opting to go the M&A route, recognizing the significant impact that smaller specialty brands in the space might have on their existing offerings. Companies such as The Alkaline Water Company (NASDAQ: WTER) (CSE: WTER) (WTER Profile), one of the fastest-growing enhanced water companies in the industry, could be an attractive option. In the meantime, Keurig Dr.…

Financial news and publishing for public and private companies

Contact us: 212.418.1217

Audio Categories: News